Skip to content
value.today

Bardy Diagnostics, Inc.

Total raised
$89 M
4 rounds on record
Latest round
$12 M
Feb 2020
First round on record
Sep 2016
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Bardy Diagnostics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2020$12 MNo. 4$10 to $50 million

Bardy Diagnostics, Inc.: Raise no. 4, Feb 2020

Investors in this round

28 investors had bought by the notice of Feb 28, 2020: 28 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $13 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ed H. Vertatschitsch · Executive Officer
  • Gust H. Bardy · Executive Officer, Director, Promoter
  • Kevin H. Nelson, III · Executive Officer
  • Mark H. Handfelt · Executive Officer, Promoter
  • Mark H. Querry · Executive Officer
  • Alan H. Levy · Director
  • David H. Tamburri · Director
  • Garheng H. Kong · Director
  • Paul H. LaViolette · Director
  • Rik H. Vandevenne · Director
  • Warren H. Watson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Handfelt, Chief Administrative Officer. Source: SEC Form D, newest notice filed Feb 28, 2020. Read the notice at the SEC.

equitySEC
Apr 2019$36 MNo. 3$10 to $50 million

Bardy Diagnostics, Inc.: Raise no. 3, Apr 2019

Investors in this round

25 investors had bought by the notice of Apr 25, 2019: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$36 M of $36 M offered
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gust H. Bardy · Executive Officer, Director, Promoter
  • Kevin H. Nelson, III · Executive Officer
  • Mark H. Handfelt · Executive Officer, Promoter
  • Mark H. Querry · Executive Officer
  • Alan H. Levy · Director
  • David H. Tamburri · Director
  • Garheng H. Kong · Director
  • Paul H. LaViolette · Director
  • Rik H. Vandevenne · Director
  • Warren H. Watson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Handfelt, Chief Operating Officer. Source: SEC Form D, newest notice filed Apr 25, 2019. Read the notice at the SEC.

equitySEC
Dec 2018$6 MNo. 2$2 to $10 million

Bardy Diagnostics, Inc.: Raise no. 2, Dec 2018

Investors in this round

10 investors had bought by the notice of Jan 3, 2019: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gust H. Bardy · Executive Officer, Director, Promoter
  • Mark H. Handfelt · Executive Officer, Promoter
  • Mark H. Querry · Executive Officer
  • Alan H. Levy · Director
  • David H. Tamburri · Director
  • Patrick H. Wethington · Director
  • Paul H. LaViolette · Director
  • Warren H. Watson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Handfelt, Chief Operating Officer. Source: SEC Form D, newest notice filed Jan 3, 2019. Read the notice at the SEC.

debt, optionsSEC
Sep 2016$35 MNo. 1$10 to $50 million

Bardy Diagnostics, Inc.: Raise no. 1, Sep 2016

Investors in this round

13 investors had bought by the notice of Jun 8, 2018: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$35 M of $35 M offered
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gust H. Bardy · Executive Officer, Director, Promoter
  • Mark H. Handfelt · Executive Officer, Promoter
  • Mark H. Querry · Executive Officer
  • Alan H. Levy · Director
  • David H. Tamburri · Director
  • Patrick H. Wethington · Director
  • Paul H. LaViolette · Director
  • Warren H. Watson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Handfelt, Chief Operating Officer. Source: SEC Form D and 1 amendment, newest notice filed Jun 8, 2018. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Bardy Diagnostics, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2020).

    SEC Form D · Feb 2020

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Feb 2020

That is all the official record says: Bardy Diagnostics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Bardy Diagnostics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 28 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Bardy Diagnostics, Inc.
NameRoleNamed in
Ed H. VertatschitschExecutive officerFeb 2020
Gust H. BardyExecutive officerFeb 2020
Kevin H. Nelson, IIIExecutive officerFeb 2020
Mark H. HandfeltExecutive officerFeb 2020
Mark H. QuerryExecutive officerFeb 2020
Jon P. HuntExecutive officerOct 2016
Alan H. LevyDirectorFeb 2020
David H. TamburriDirectorFeb 2020
Garheng H. KongDirectorFeb 2020
Gust H. BardyDirectorFeb 2020
Paul H. LaVioletteDirectorFeb 2020
Rik H. VandevenneDirectorFeb 2020
Warren H. WatsonDirectorFeb 2020
Patrick H. WethingtonDirectorJan 2019
Jon P. HuntDirectorOct 2016
Gust H. BardyPromoterFeb 2020
Mark H. HandfeltPromoterFeb 2020
Jon P. HuntPromoterOct 2016